08/04/21 -"We are (slightly) revising upwards our EPS for 2022 on the back of the integration of Lyxor at the beginning of 2022."
Pages
47
Language
English
Published on
08/04/21
You may also be interested by these reports :
18/04/24
EdenRed’s Q1 2024 update was ahead of the consensus and our estimates. Organic growth increased by 16.9% on a lfl basis, driven by growth across all ...
18/04/24
Kinnevik released lacklustre results as its growth-oriented portfolio continued to suffer in this high interest rate environment. However, the new ...
16/04/24
Wise released its trading update for the Q4 24, revealing a continuation of the trend observed in the previous quarters. NII surpassed the compiled ...
16/04/24
Wise’s Q4 24 trading update once again showed very strong NII but very soft VPC. Wise continues to benefit from high interest rates and constraints ...